XTI Aerospace Secures $2 Million Investment from Valkyrie AI and Launches Vanguard Platform to Accelerate TriFan 600 Development

XTIA
October 27, 2025

XTI Aerospace announced a strategic partnership with Valkyrie AI, unveiling the Vanguard Platform, a joint technology initiative that integrates Valkyrie’s expertise in graphene, composite materials, battery technology, and smart systems architecture into XTI’s TriFan 600 xVTOL program.

The partnership includes a $2 million investment by XTI in Valkyrie Sciences Holdings LLC, structured as a convertible promissory note with 10% annual interest, issued on October 21, 2025, and a services agreement between XTI and Valkyrie Intelligence LLC, effective October 1, 2025, valued at $600,000.

The Vanguard Platform provides real‑time coordination across aircraft systems and supports lean, data‑driven engineering processes for both teams, applying Valkyrie’s distributed mesh intelligence and digital twin systems to the TriFan 600, streamlining development and enhancing integration of advanced materials and AI‑driven systems.

The collaboration supports XTI’s strategy to advance the TriFan 600 program, which has already secured over 140 conditional pre‑orders and 150 reservations/options, representing approximately $3 billion in potential revenue, and is progressing toward FAA certification.

The partnership reinforces XTI’s commitment to integrating cutting‑edge technology into its xVTOL platform, positioning the company for market opportunities in commercial and defense applications.

XTI plans to file a Form 8‑K with the SEC to disclose additional details regarding the investment.

Valkyrie’s CEO, Charlie Burgoyne, has served on XTI’s Corporate Advisory Board since July 2025, bringing extensive experience in applied AI from government and industry roles.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.